Monday, August 19, 2013 6:02:10 PM
My inclination is not much of a run-up until right before the October PDUFA date which will be speculation of buying a rumor, then with approval a sell off - which will not be a sell off in a negative way but traders who bought the rumor and then eeking out their profit and selling. Antares is not immune to that kind of play.
The company has broadcast for sometime now that this event is key which in my book (for now anyway) puts everything else in second place. The FDA approval of OTREXUP and the ensuing validation of Antares injector platform is a game changer, imo. At this point, I think the investment world has listened to the story, heard the story, knows the story and now says, "okay Antares, prove it."
I'm invested for the beyond OTREXUP PDUFA date, so I'll be an observor.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM